CATALOGO DEI PRODOTTI DELLA RICERCA

TORTORA, GIAMPAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.911
EU - Europa 17.885
AS - Asia 13.260
SA - Sud America 1.782
Continente sconosciuto - Info sul continente non disponibili 439
AF - Africa 427
OC - Oceania 44
Totale 53.748
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.544
RU - Federazione Russa 6.478
SG - Singapore 5.156
GB - Regno Unito 4.595
CN - Cina 4.333
IT - Italia 1.463
BR - Brasile 1.371
VN - Vietnam 1.109
HK - Hong Kong 1.079
DE - Germania 1.020
FR - Francia 995
IE - Irlanda 974
SE - Svezia 966
FI - Finlandia 699
KR - Corea 465
NG - Nigeria 191
IN - India 182
BD - Bangladesh 173
CA - Canada 172
UA - Ucraina 167
AR - Argentina 152
JP - Giappone 136
NL - Olanda 130
ID - Indonesia 104
MX - Messico 102
TR - Turchia 102
ZA - Sudafrica 84
IQ - Iraq 70
PL - Polonia 65
EC - Ecuador 63
ES - Italia 62
BE - Belgio 55
CO - Colombia 45
UZ - Uzbekistan 44
MA - Marocco 43
CL - Cile 37
SA - Arabia Saudita 36
VE - Venezuela 36
AU - Australia 35
AT - Austria 33
PK - Pakistan 33
PY - Paraguay 28
EU - Europa 27
CH - Svizzera 25
PH - Filippine 25
PE - Perù 24
MY - Malesia 23
IR - Iran 22
KE - Kenya 22
AE - Emirati Arabi Uniti 20
CR - Costa Rica 19
EG - Egitto 18
JM - Giamaica 18
LT - Lituania 18
NP - Nepal 17
JO - Giordania 16
TN - Tunisia 16
UY - Uruguay 16
AL - Albania 15
AZ - Azerbaigian 15
CZ - Repubblica Ceca 15
RO - Romania 13
IL - Israele 11
KG - Kirghizistan 11
GR - Grecia 10
DZ - Algeria 9
KZ - Kazakistan 9
LK - Sri Lanka 9
LV - Lettonia 9
GT - Guatemala 8
HN - Honduras 8
BB - Barbados 7
BG - Bulgaria 7
BO - Bolivia 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
TT - Trinidad e Tobago 7
BJ - Benin 6
BY - Bielorussia 6
EE - Estonia 6
HU - Ungheria 6
NO - Norvegia 6
SN - Senegal 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
LB - Libano 5
PA - Panama 5
QA - Qatar 5
AO - Angola 4
CY - Cipro 4
GA - Gabon 4
KW - Kuwait 4
MK - Macedonia 4
NI - Nicaragua 4
OM - Oman 4
SI - Slovenia 4
Totale 53.256
Salva come PNG Salva come JPEG
Città #
Southend 4.163
Singapore 2.635
Moscow 1.986
Chandler 1.851
San Jose 1.777
Ashburn 1.753
Dallas 1.585
Jacksonville 1.443
Woodbridge 1.406
Hong Kong 1.064
Ann Arbor 1.008
Dublin 967
Council Bluffs 828
Beijing 758
The Dalles 712
Verona 676
Houston 618
Lawrence 397
Princeton 396
Wilmington 384
Los Angeles 365
Ho Chi Minh City 342
Jinan 322
New York 322
Nanjing 279
Shenyang 260
Hanoi 226
Tianjin 193
Abuja 190
Munich 189
Buffalo 180
Hebei 166
São Paulo 159
Santa Clara 150
Changsha 137
Redondo Beach 131
Tokyo 119
Helsinki 117
Nanchang 107
Columbus 100
Zhengzhou 97
Chicago 93
Haikou 93
Milan 92
Guangzhou 90
Ningbo 88
Hangzhou 83
Sindelfingen 83
Dong Ket 78
Jiaxing 75
London 71
Orem 69
Turku 67
Frankfurt am Main 65
Montreal 64
Brooklyn 62
Taizhou 60
Seoul 59
Jakarta 58
Redwood City 58
San Francisco 57
Taiyuan 57
Norwalk 55
Brussels 53
Chennai 53
Warsaw 53
Denver 52
Johannesburg 48
Seattle 48
Stockholm 48
Boardman 47
Mexico City 45
Phoenix 45
Amsterdam 44
Bologna 43
Lanzhou 43
Atlanta 40
Fuzhou 39
Lancaster 39
Tashkent 38
Da Nang 37
Toronto 37
Boston 36
Haiphong 36
Rio de Janeiro 36
Falls Church 34
Dearborn 33
Rome 32
Baghdad 31
Biên Hòa 30
Charlotte 29
Redmond 29
Campinas 28
Kent 28
Dongguan 27
Manchester 27
Washington 27
Belo Horizonte 26
New Delhi 24
Nuremberg 24
Totale 33.524
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 318
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 293
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 289
Whole-genome landscape of pancreatic neuroendocrine tumours 287
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 261
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment 261
Genomic analyses identify molecular subtypes of pancreatic cancer 258
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 251
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 250
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 249
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 248
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 244
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 242
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 238
Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel 237
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 236
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 229
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 225
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 224
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 221
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 218
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 218
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer 215
Adenocarcinoma of the paraurethral glands: a case report 214
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 213
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 212
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 210
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 208
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 206
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 205
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 204
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 204
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 203
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 202
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 201
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials 201
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 200
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 199
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 198
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 198
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 197
ESGAR 2016 Book of Abstracts 196
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents 195
Emerging pathways and future targets for the molecular therapy of pancreatic cancer. 195
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 195
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 195
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 194
Adjuvant treatment for resected renal cell carcinoma: are all strategies equally negative? Potential implications for trial design with targeted agents. 194
Role of Combined Ga-68-DOTATOC and F-18-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors Implications for Managing Surgical Decisions 193
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 193
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 193
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 192
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 192
Reporting tumor molecular heterogeneity in histopathological diagnosis 192
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 192
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 190
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 190
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 190
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 189
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 189
Adjuvant treatment for resected renal cell carcinoma: are all strategies equally negative? Potential implications for trial design with targeted agents. 188
Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research 188
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 188
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 187
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. 186
A novel modified CpG agonist of TLR-9 inhibits EGF receptor signalling and synergistically enhances antitumor activity of cetuximab and irinotecan eradicating colon cancer xenografts 186
A selective cyclooxygenase-2 inhibitor combined with the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') and protein kinase A antisense causes cooperative tumor growth inhibition after oral administration 184
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 184
AR-V7 and prostate cancer: The watershed for treatment selection? 184
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 184
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 184
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 182
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives 181
The development of PARP as a successful target for cancer therapy 181
HER2/neu Gene Determination in Women Screened for Breast Carcinoma: How Screening Programs Reduce the Skyrocketing Cost of Targeted Therapy 180
Adjuvant therapy for resected early-stage small-cell lung cancer: is now time to rethink about that? 180
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy. 179
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 179
A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in a multi-center series of resected early stage pure invasive lobular breast carcinoma (ILC) 179
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 178
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 178
Prognostication and response assessment in liver and pancreatic tumors: The new imaging 177
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 177
Tumor seeding after percutaneous US-guided FNA of solid pancreatic neoplasms 176
Hypermutation In Pancreatic Cancer 175
8-Chloro-cAMP inhibits transforming growth factor alpha transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation. 175
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis 175
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 174
Molecular Pathology of Pancreatic Cancer: from bench-to-bedside translation. 173
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 173
Tubulin inhibitors in non-small cell lung cancer: looking back and forward 172
2015 and human cancer: back to overall survival 172
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer 172
AGENTI BIOLOGICI e CHEMIOTERAPICI: INTEGRAZIONE 169
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival 168
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting 168
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 167
Metabolic phenotype of bladder cancer 167
Metabolic alterations in renal cell carcinoma 167
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research 166
Totale 20.149
Salva come PNG Salva come JPEG
Categoria #
all - tutte 185.266
article - articoli 168.482
book - libri 500
conference - conferenze 12.414
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.870
Totale 370.532
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.523 0 780 17 208 94 46 41 175 109 61 198 794
2022/20235.491 472 505 554 860 534 1.409 54 323 582 36 118 44
2023/20242.404 103 200 180 202 381 380 51 232 45 125 353 152
2024/20257.291 400 446 238 1.317 252 196 248 310 1.242 490 585 1.567
2025/202621.470 1.660 1.073 1.729 3.557 5.247 1.289 2.014 1.103 1.671 1.129 341 657
2026/2027785 181 604 0 0 0 0 0 0 0 0 0 0
Totale 53.748